儿童流感相关脑病与急性坏死性脑病——美国2024-25流感季
2025年1月CDC收到多例18岁以下儿童严重流感相关脑病(IAE)即急性坏死性脑病(ANE)死亡报告。2024-25流感季CDC收集192例疑似IAE报告,109例(57%)归类为IAE,其中37例(34%)为ANE、72例(66%)为其他IAE;IAE患儿中位年龄5岁,55%既往健康,74%入住ICU,19%死亡,ANE患儿41%死亡;符合接种条件的IAE患儿仅16%接种当季流感疫苗。
要点
- 2024-25流感季192例疑似IAE报告中109例(57%)符合IAE,其中ANE 37例(34%)、其他IAE 72例(66%)。
- IAE患儿中位年龄5岁,55%既往健康,74%入住ICU,19%死亡;ANE患儿41%死亡。
- 符合接种条件的IAE患儿仅16%接种2024-25流感疫苗;建议所有≥6月龄儿童每年接种流感疫苗。
核心结论
- 当流感病毒流行时,医务人员对出现脑病或意识水平改变并伴有近期或当前发热性疾病的儿童应考虑IAE。
- 推荐所有≥6月龄儿童每年接种流感疫苗,以预防流感及相关并发症,可能包括IAE和ANE等严重神经系统疾病。
研究设计与样本
- CDC于2024-25流感季向临床医生和卫生部门征集美国儿童IAE病例报告,该季为高严重度季节且儿童流感相关死亡数创纪录。
- CDC收到192例疑似IAE报告,其中109例(57%)归类为IAE,37例(34%)亚归类为ANE,72例(66%)为其他IAE;82例不符合IAE标准,归类为其他流感相关神经系统疾病。
主要发现
- IAE患儿中位年龄5岁,55%既往健康,74%入住重症监护室,19%死亡。
- ANE患儿中41%死亡。
- 符合接种条件的IAE患儿中仅16%接种了2024-25流感疫苗。
关键数值与推荐
- 192例疑似IAE报告中109例(57%)符合IAE标准,其中37例(34%)为ANE、72例(66%)为其他IAE。
- 82例报告不符合IAE标准,归类为其他流感相关神经系统疾病。
- IAE患儿中位年龄5岁,55%既往健康,74%入住ICU,19%死亡;ANE患儿41%死亡。
- 符合接种条件的IAE患儿中16%接种2024-25流感疫苗。
临床怎么用
- 当流感病毒流行时,医务人员对出现脑病或意识水平改变并伴有近期或当前发热性疾病的儿童应考虑IAE。
- 推荐所有≥6月龄儿童每年接种流感疫苗,以预防流感及相关并发症,可能包括IAE和ANE等严重神经系统疾病。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In January 2025, CDC received several reports of deaths among children aged <18 years with a severe form of influenza-associated encephalopathy (IAE) termed acute necrotizing encephalopathy (ANE). Because no national surveillance for IAE currently exists, CDC requested notification of U.S. pediatric IAE cases from clinicians and health departments during the 2024-25 influenza season, a high-severity season with a record number of pediatric influenza-associated deaths. Among 192 reports of suspected IAE submitted to CDC, 109 (57%) were categorized as IAE, 37 (34%) of which were subcategorized as ANE, and 72 (66%) as other IAE; 82 reports did not meet IAE criteria and were categorized as other influenza-associated neurologic disease. The median age of children with IAE was 5 years and 55% were previously healthy, 74% were admitted to an intensive care unit, and 19% died; 41% of children with ANE died. Only 16% of children with IAE who were vaccination-eligible had received the 2024-25 influenza vaccine. Health care providers should consider IAE in children with encephalopathy or altered level of consciousness and a recent or current febrile illness when influenza viruses are circulating. Annual influenza vaccination is recommended for all children aged ≥6 months to prevent influenza and associated complications, potentially including severe neurologic disease such as IAE and ANE.
引用
- Fazal A, Harker EJ, Neelam V, et al. Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season. MMWR Morb Mortal Wkly Rep. 2025. PMID: 40996921. doi:10.15585/mmwr.mm7436a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。